1. Home
  2. VSTA vs ANNX Comparison

VSTA vs ANNX Comparison

Compare VSTA & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTA
  • ANNX
  • Stock Information
  • Founded
  • VSTA 1966
  • ANNX 2011
  • Country
  • VSTA Brazil
  • ANNX United States
  • Employees
  • VSTA N/A
  • ANNX N/A
  • Industry
  • VSTA Other Consumer Services
  • ANNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTA Real Estate
  • ANNX Health Care
  • Exchange
  • VSTA Nasdaq
  • ANNX Nasdaq
  • Market Cap
  • VSTA 357.6M
  • ANNX 362.4M
  • IPO Year
  • VSTA 2020
  • ANNX 2020
  • Fundamental
  • Price
  • VSTA $4.87
  • ANNX $1.46
  • Analyst Decision
  • VSTA Sell
  • ANNX Strong Buy
  • Analyst Count
  • VSTA 2
  • ANNX 5
  • Target Price
  • VSTA $3.00
  • ANNX $18.67
  • AVG Volume (30 Days)
  • VSTA 73.2K
  • ANNX 2.2M
  • Earning Date
  • VSTA 05-07-2025
  • ANNX 05-12-2025
  • Dividend Yield
  • VSTA N/A
  • ANNX N/A
  • EPS Growth
  • VSTA N/A
  • ANNX N/A
  • EPS
  • VSTA 0.98
  • ANNX N/A
  • Revenue
  • VSTA $270,690,068.00
  • ANNX N/A
  • Revenue This Year
  • VSTA $12.95
  • ANNX N/A
  • Revenue Next Year
  • VSTA $11.85
  • ANNX N/A
  • P/E Ratio
  • VSTA $4.93
  • ANNX N/A
  • Revenue Growth
  • VSTA 12.64
  • ANNX N/A
  • 52 Week Low
  • VSTA $1.60
  • ANNX $1.29
  • 52 Week High
  • VSTA $5.49
  • ANNX $7.85
  • Technical
  • Relative Strength Index (RSI)
  • VSTA 64.30
  • ANNX 30.77
  • Support Level
  • VSTA $4.60
  • ANNX $1.40
  • Resistance Level
  • VSTA $5.49
  • ANNX $1.68
  • Average True Range (ATR)
  • VSTA 0.51
  • ANNX 0.18
  • MACD
  • VSTA 0.02
  • ANNX 0.00
  • Stochastic Oscillator
  • VSTA 68.11
  • ANNX 19.13

About VSTA Vasta Platform Limited

Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: